Literature DB >> 22689745

Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure.

Mingyi Wang1, Jing Zhang, Richard Telljohann, Liqun Jiang, James Wu, Robert E Monticone, Kapil Kapoor, Mark Talan, Edward G Lakatta.   

Abstract

Age-associated arterial remodeling involves arterial wall collagen deposition and elastin fragmentation, as well as an increase in arterial pressure. This arterial remodeling is linked to proinflammatory signaling, including transforming growth factor-β1, monocyte chemoattractant protein 1, and proendothelin 1, activated by extracellular matrix metalloproteinases (MMPs) and orchestrated, in part, by the transcriptional factor ets-1. We tested the hypothesis that inhibition of MMP activation can decelerate the age-associated arterial proinflammation and its attendant increase in arterial pressure. Indeed, chronic administration of a broad-spectrum MMP inhibitor, PD166739, via a daily gavage, to 16-month-old rats for 8 months markedly blunted the expected age-associated increases in arterial pressure. This was accompanied by the following: (1) inhibition of the age-associated increases in aortic gelatinase and interstitial collagenase activity in situ; (2) preservation of the elastic fiber network integrity; (3) a reduction of collagen deposition; (4) a reduction of monocyte chemoattractant protein 1 and transforming growth factor-β1 activation; (5) a diminution in the activity of the profibrogenic signaling molecule SMAD-2/3 phosphorylation; (6) inhibition of proendothelin 1 activation; and (7) downregulation of expression of ets-1. Acute exposure of cultured vascular smooth muscle cells in vitro to proendothelin 1 increased both the transcription and translation of ets-1, and these effects were markedly reduced by MMP inhibition. Furthermore, infection of vascular smooth muscle cells with an adenovirus harboring a full-length ets-1 cDNA increased activities of both transforming growth factor-β1 and monocyte chemoattractant protein 1. Collectively, our results indicate that MMP inhibition retards age-associated arterial proinflammatory signaling, and this is accompanied by preservation of intact elastin fibers, a reduction in collagen, and blunting of an age-associated increase in blood pressure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689745      PMCID: PMC3537179          DOI: 10.1161/HYPERTENSIONAHA.112.191270

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  56 in total

1.  Identification of protease(s) capable of further degrading native 3/4- and 1/4-collagen fragments generated by collagenase from native type I collagen in human neutrophils.

Authors:  T Sorsa; K Suomalainen; Y T Konttinen; H T Saari; S Lindy; V J Uitto
Journal:  Proc Finn Dent Soc       Date:  1989

2.  Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats.

Authors:  W Linz; H Heitsch; B A Schölkens; G Wiemer
Journal:  Hypertension       Date:  2000-04       Impact factor: 10.190

3.  Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.

Authors:  Mingyi Wang; Jing Zhang; Gaia Spinetti; Li-Qun Jiang; Robert Monticone; Di Zhao; Linda Cheng; Melissa Krawczyk; Mark Talan; Gianfranco Pintus; Edward G Lakatta
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

4.  Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells.

Authors:  S Naito; S Shimizu; S Maeda; J Wang; R Paul; J A Fagin
Journal:  Am J Physiol       Date:  1998-02

5.  Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload.

Authors:  Amanda L Chancey; Gregory L Brower; J Thomas Peterson; Joseph S Janicki
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

Review 6.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

7.  Aerobic exercise training reduces plasma endothelin-1 concentration in older women.

Authors:  Seiji Maeda; Takumi Tanabe; Takashi Miyauchi; Takeshi Otsuki; Jun Sugawara; Motoyuki Iemitsu; Shinya Kuno; Ryuichi Ajisaka; Iwao Yamaguchi; Mitsuo Matsuda
Journal:  J Appl Physiol (1985)       Date:  2003-02-28

8.  Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study.

Authors:  Perttu J Pöllänen; Terho Lehtimäki; Erkki Ilveskoski; Jussi Mikkelsson; Olli A Kajander; Pekka Laippala; Markus Perola; Sirkka Goebeler; Antti Penttilä; Kari M Mattila; Kirsi Syrjäkoski; Timo Koivula; Seppo T Nikkari; Pekka J Karhunen
Journal:  Atherosclerosis       Date:  2002-10       Impact factor: 5.162

Review 9.  Arterial aging: a journey into subclinical arterial disease.

Authors:  Mingyi Wang; Robert E Monticone; Edward G Lakatta
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

10.  Involvement of NADPH oxidase in age-associated cardiac remodeling.

Authors:  Mingyi Wang; Jing Zhang; Simon J Walker; Rafal Dworakowski; Edward G Lakatta; Ajay M Shah
Journal:  J Mol Cell Cardiol       Date:  2010-01-15       Impact factor: 5.000

View more
  38 in total

Review 1.  Aging, arterial stiffness, and hypertension.

Authors:  Zhongjie Sun
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 2.  Strategies for Achieving Healthy Vascular Aging.

Authors:  Kristen L Nowak; Matthew J Rossman; Michel Chonchol; Douglas R Seals
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

Review 3.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

4.  Arterial stiffness and hypertension.

Authors:  Gary F Mitchell
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

5.  Habitual aerobic exercise and circulating proteomic patterns in healthy adults: relation to indicators of healthspan.

Authors:  Jessica R Santos-Parker; Keli S Santos-Parker; Matthew B McQueen; Christopher R Martens; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

Review 6.  Arterial stiffness as a risk factor for clinical hypertension.

Authors:  Michel E Safar
Journal:  Nat Rev Cardiol       Date:  2017-10-12       Impact factor: 32.419

Review 7.  Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging.

Authors:  Mingyi Wang; Robert E Monticone; Kimberly R McGraw
Journal:  J Vasc Res       Date:  2018-08-02       Impact factor: 1.934

Review 8.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

9.  Is increased arterial stiffness a cause or consequence of atherosclerosis?

Authors:  Laura Hansen; W Robert Taylor
Journal:  Atherosclerosis       Date:  2016-04-21       Impact factor: 5.162

Review 10.  Proinflammation: the key to arterial aging.

Authors:  Mingyi Wang; Liqun Jiang; Robert E Monticone; Edward G Lakatta
Journal:  Trends Endocrinol Metab       Date:  2013-12-20       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.